A study to assess change to maintenance Ustekinumab IV treatment as a rescue in patients with moderate-severe Crohn's Disease who present loss of response to Ustekinumab SC administration
Latest Information Update: 07 Dec 2020
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Pharmacodynamics
- 07 Dec 2020 New trial record
- 13 Oct 2020 Results presented at the 28th United European Gastroenterology Week